These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36200239)

  • 1. Residual Humoral Immunity Sustained Over Decades in a Cohort of Vaccinia-Vaccinated Individuals.
    Chan CEZ; Wong SKK; Yazid NBM; Ng OT; Marimuthu K; Chan M; Howe HS; Leo YS; Leung BP; Vasoo SS; Young BE
    J Infect Dis; 2023 Apr; 227(8):1002-1006. PubMed ID: 36200239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humoral Immunity to Primary Smallpox Vaccination: Impact of Childhood versus Adult Immunization on Vaccinia Vector Vaccine Development in Military Populations.
    Slike BM; Creegan M; Marovich M; Ngauy V
    PLoS One; 2017; 12(1):e0169247. PubMed ID: 28046039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement-dependent mpox-virus-neutralizing antibodies in infected and vaccinated individuals.
    Hubert M; Guivel-Benhassine F; Bruel T; Porrot F; Planas D; Vanhomwegen J; Wiedemann A; Burrel S; Marot S; Palich R; Monsel G; Diombera H; Gallien S; Lopez-Zaragoza JL; Vindrios W; Taieb F; Fernandes-Pellerin S; Delhaye M; Laude H; Arowas L; Ungeheuer MN; Hocqueloux L; Pourcher V; Prazuck T; Marcelin AG; Lelièvre JD; Batéjat C; Lévy Y; Manuguerra JC; Schwartz O
    Cell Host Microbe; 2023 Jun; 31(6):937-948.e4. PubMed ID: 37196656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serological Immunity to Smallpox in New South Wales, Australia.
    Costantino V; Trent MJ; Sullivan JS; Kunasekaran MP; Gray R; MacIntyre R
    Viruses; 2020 May; 12(5):. PubMed ID: 32443405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duration of humoral immunity from smallpox vaccination and its cross-reaction with Mpox virus.
    Li E; Guo X; Hong D; Gong Q; Xie W; Li T; Wang J; Chuai X; Chiu S
    Signal Transduct Target Ther; 2023 Sep; 8(1):350. PubMed ID: 37709783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of monkeypox- and vaccinia-virus neutralizing antibodies before and after smallpox vaccination: A sero-epidemiological study.
    Marchi S; Piccini G; Cantaloni P; Guerrini N; Zannella R; Coluccio R; Benincasa L; Solfanelli N; Remarque EJ; Viviani S; Kistner O; Temperton N; Montomoli E; Manenti A; Trombetta CM
    J Med Virol; 2024 Jun; 96(6):e29728. PubMed ID: 38860589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unexpectedly higher levels of anti-orthopoxvirus neutralizing antibodies are observed among gay men than general adult population.
    Feng Y; Zhang Y; Liu S; Guo M; Huang H; Guo C; Wang W; Zhang W; Tang H; Wan Y
    BMC Med; 2023 May; 21(1):183. PubMed ID: 37189197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological responses to the MVA-based JYNNEOS monkeypox vaccine in a cohort of participants from the Democratic Republic of Congo.
    Priyamvada L; Carson WC; Ortega E; Navarra T; Tran S; Smith TG; Pukuta E; Muyamuna E; Kabamba J; Nguete BU; Likafi T; Kokola G; Lushima RS; Tamfum JM; Okitolonda EW; Kaba DK; Monroe BP; McCollum AM; Petersen BW; Satheshkumar PS; Townsend MB
    Vaccine; 2022 Nov; 40(50):7321-7327. PubMed ID: 36344361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persisting humoral antiviral immunity within the Japanese population after the discontinuation in 1976 of routine smallpox vaccinations.
    Hatakeyama S; Moriya K; Saijo M; Morisawa Y; Kurane I; Koike K; Kimura S; Morikawa S
    Clin Diagn Lab Immunol; 2005 Apr; 12(4):520-4. PubMed ID: 15817760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Live attenuated smallpox vaccine candidate (KVAC103) efficiently induces protective immune responses in mice.
    Hwang YH; Byeon Y; Ahn SH; Kim MY; Byun SH; Lee HJ; Suh B; Kim D; Jung EJ; Kim YJ
    Vaccine; 2024 Feb; 42(6):1283-1291. PubMed ID: 38310019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies Induced by Smallpox Vaccination after at Least 45 Years Cross-React with and In Vitro Neutralize Mpox Virus: A Role for Polyclonal B Cell Activation?
    Mariotti S; Venturi G; Chiantore MV; Teloni R; De Santis R; Amendola A; Fortuna C; Marsili G; Grilli G; Lia MS; Kiros ST; Lagi F; Bartoloni A; Iacobino A; Cresta R; Lastilla M; Biselli R; Di Bonito P; Lista F; Nisini R
    Viruses; 2024 Apr; 16(4):. PubMed ID: 38675961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination with a codon-optimized A27L-containing plasmid decreases virus replication and dissemination after vaccinia virus challenge.
    Martínez O; Bravo Cruz A; Santos S; Ramírez M; Miranda E; Shisler J; Otero M
    Vaccine; 2017 Oct; 35(44):6007-6014. PubMed ID: 28629922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of vaccinia virus-neutralizing antibody in the sera of smallpox vaccinees.
    Viner KM; Isaacs SN
    Microbes Infect; 2005 Apr; 7(4):579-83. PubMed ID: 15848274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunity from smallpox vaccine persists for decades: a longitudinal study.
    Taub DD; Ershler WB; Janowski M; Artz A; Key ML; McKelvey J; Muller D; Moss B; Ferrucci L; Duffey PL; Longo DL
    Am J Med; 2008 Dec; 121(12):1058-64. PubMed ID: 19028201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redundancy and plasticity of neutralizing antibody responses are cornerstone attributes of the human immune response to the smallpox vaccine.
    Benhnia MR; McCausland MM; Su HP; Singh K; Hoffmann J; Davies DH; Felgner PL; Head S; Sette A; Garboczi DN; Crotty S
    J Virol; 2008 Apr; 82(7):3751-68. PubMed ID: 18234801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of anti-orthopoxvirus immunity in Moscow residents and potential risks of spreading Monkeypox virus.
    Gushchin VA; Ogarkova DA; Dolzhikova IV; Zubkova OV; Grigoriev IV; Pochtovyi AA; Iliukhina AA; Ozharovskaia TA; Kuznetsova NA; Kustova DD; Shelkov AY; Zrelkin DI; Odintsova AS; Grousova DM; Kan VY; Davtyan SA; Siniavin AE; Belyaeva ED; Botikov AG; Bessonova AA; Vasilchenko LA; Vasina DV; Kleymenov DA; Slutskiy EA; Tkachuk AP; Burgasova OA; Loginova SY; Rozhdestvensky EV; Shcheblyakov DV; Tsibin AN; Komarov AG; Zlobin VI; Borisevich SV; Naroditsky BS; Logunov DY; Gintsburg AL
    Front Immunol; 2022; 13():1023164. PubMed ID: 36466896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smallpox vaccine, ACAM2000: Sites and duration of viral shedding and effect of povidone iodine on scarification site shedding and immune response.
    Pittman PR; Garman PM; Kim SH; Schmader TJ; Nieding WJ; Pike JG; Knight R; Johnston SC; Huggins JW; Kortepeter MG; Korman L; Ranadive M; Quinn X; Meyers MS
    Vaccine; 2015 Jun; 33(26):2990-6. PubMed ID: 25930115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Monkeypox- and Vaccinia virus-neutralizing antibodies in human serum samples after vaccination and natural infection.
    Manenti A; Solfanelli N; Cantaloni P; Mazzini L; Leonardi M; Benincasa L; Piccini G; Marchi S; Boncioli M; Spertilli Raffaelli C; Tacconi D; Mattiuzzo G; Kistner O; Montomoli E; Trombetta CM
    Front Public Health; 2023; 11():1195674. PubMed ID: 37415699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of antibodies to Vaccinia virus after smallpox vaccination in Italy.
    Pütz MM; Alberini I; Midgley CM; Manini I; Montomoli E; Smith GL
    J Gen Virol; 2005 Nov; 86(Pt 11):2955-2960. PubMed ID: 16227216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term and longer-term protective immune responses generated by subunit vaccination with smallpox A33, B5, L1 or A27 proteins adjuvanted with aluminum hydroxide and CpG in mice challenged with vaccinia virus.
    Xiao Y; Zeng Y; Schante C; Joshi SB; Buchman GW; Volkin DB; Middaugh CR; Isaacs SN
    Vaccine; 2020 Aug; 38(38):6007-6018. PubMed ID: 32741672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.